R68G (p.Arg68Gly) variant of SETX (Helicase senataxin)

R68G (p.Arg68Gly) in SETX (Helicase senataxin) is a missense change. Clinical records from EBI and UniProt describe it as likely pathogenic. The available variant effect predictions contribute to a CATVariant prioritization score of 0.75 / 1. The record also includes population frequency data and structural context.

R68G (p.Arg68Gly) variant details